1. Introduction {#sec1-jcm-09-00166}
===============

Because sarcopenia, as defined by muscle mass decline and muscle strength decline in patients with chronic liver diseases (CLDs), can be associated with falls, decreased quality of life, or poor prognosis, it has gained much interest among clinicians these days \[[@B1-jcm-09-00166],[@B2-jcm-09-00166],[@B3-jcm-09-00166],[@B4-jcm-09-00166],[@B5-jcm-09-00166],[@B6-jcm-09-00166],[@B7-jcm-09-00166]\]. Sarcopenia, especially, can occur frequently in patients with liver cirrhosis (LC), and it can be a risk factor for the development of hepatic encephalopathy in LC patients \[[@B8-jcm-09-00166],[@B9-jcm-09-00166]\]. Japanese CLD patients are aging these days, and it is also an important public health problem as aging can be associated with sarcopenia \[[@B10-jcm-09-00166],[@B11-jcm-09-00166]\]. How sarcopenia is associated with such adverse clinical outcomes needs to be looked at beyond the overt muscle mass loss or muscle strength decline and at this clinical entity as a systemic disease \[[@B12-jcm-09-00166],[@B13-jcm-09-00166],[@B14-jcm-09-00166]\]. Muscle mass has been assessed by different techniques such as the bioimpedance analysis (BIA), dual-energy X-ray, computed tomography (CT) and magnetic resonance imaging, and the functional consequence of sarcopenia is estimable by handgrip strength (HGS) or other more composite tests such as the walking test \[[@B10-jcm-09-00166],[@B15-jcm-09-00166],[@B16-jcm-09-00166],[@B17-jcm-09-00166]\]. Physical activity, nutrition, and control of underlying diseases may be required for the prevention of sarcopenia \[[@B5-jcm-09-00166]\].

Walking speed (WS) can reflect skeletal muscle function and is an easy and reproducible measure \[[@B18-jcm-09-00166],[@B19-jcm-09-00166],[@B20-jcm-09-00166]\]. Currently, the European Working Group on Sarcopenia in Older People (EWGSOP) criteria and the Asian Working Group on Sarcopenia (AWGS) criteria define 0.8 m/s as the cutoff point for WS decline \[[@B15-jcm-09-00166],[@B16-jcm-09-00166]\]. However, in a population-based, cross-sectional survey of Japanese adults aged 65 years or older who were living independently at home in the community, the proportion of adults presenting a WS of \< 0.8 m/s was only 3.6% (174/4811) \[[@B21-jcm-09-00166]\]. The WS, thus, may not be suitable for the screening tool of muscle strength decline in Japanese older adults. Moreover, since clear consensus has not been reached with regard to assessment methods for WS (e.g., 12-, 10-, 8-, 6- meter walking), the Japanese Society of Hepatology (JSH) adopts only the HGS as a marker of muscle strength, and WS is not included in the current JSH guidelines for sarcopenia in CLDs \[[@B10-jcm-09-00166]\]. Based on these backgrounds, there have been few reports examining the impact of WS in Japanese CLD patients \[[@B18-jcm-09-00166],[@B19-jcm-09-00166]\]. In addition, recent research reported that in adults aged ≥60 years living in the community, WS decline and the HGS decline are associated with cognitive decline but there may be different mechanisms between brain and physical functions \[[@B20-jcm-09-00166]\]. There is, thus, an urgent need for clarifying the impact of WS in CLDs, and in this study we seek to address these issues.

2. Patients and Methods {#sec2-jcm-09-00166}
=======================

2.1. Patients {#sec2dot1-jcm-09-00166}
-------------

A total of 356 CLD individuals with data for WS were admitted to our hospital between July 2015 and January 2019, and they were subjected to this analysis. HGS data were available in all analyzed subjects, which were tested referring to the Japanese guidelines \[[@B10-jcm-09-00166]\]. Presence of LC was judged by pathological findings (F4 or not), radiological findings (deformity of the liver, or the presence of varices or splenomegaly), and/or laboratory data (lower platelet count or lower prothrombin time) \[[@B22-jcm-09-00166],[@B23-jcm-09-00166],[@B24-jcm-09-00166],[@B25-jcm-09-00166]\]. Mac-2 binding protein glycosylation isomer (M2BPGi) as a liver fibrosis marker was tested, as reported elsewhere \[[@B26-jcm-09-00166]\]. Skeletal muscle index (SMI, kg/m^2^) was tested using BIA, as reported elsewhere \[[@B27-jcm-09-00166]\]. SMI decline was defined as \<7.0 kg/m^2^ in males and \< 5.7 kg/m^2^ in females, referring to the Japanese guidelines \[[@B10-jcm-09-00166]\]. Two patients had missing data for BIA. Severe ascites patients were not subject to this analysis owing to the limitation of BIA testing. We examined the relationship between the baseline of the WS value and clinical variables in a retrospective manner. WS decline was defined as \<0.8 m/s referring to the current EWGSOP or AWGS guidelines \[[@B15-jcm-09-00166],[@B16-jcm-09-00166]\]. Factors related to the WS decline were also explored in the univariate and multivariate analyses.

The current research protocol was approved by the institutional review board (IRB) of the Hyogo College of Medicine Hospital, and the declaration of Helsinki was strictly followed to ensure the rights of the research subjects (IRB approval no. 2296). Personal information was protected in the data collection.

2.2. Measurement of Walking Speed {#sec2dot2-jcm-09-00166}
---------------------------------

In this study, a 6-m walking test was performed in each analyzed subject. We performed 6-m walking tests twice in each patient and adopted the average value of them as the walking speed (meter/second (m/s)).

2.3. Statistical Considerations {#sec2dot3-jcm-09-00166}
-------------------------------

The JMP 14 software (SAS Institute Inc., Cary, NC, USA) was in use to do statistical analysis.

For the continuous parameter analysis, Student's *t*-test, the Mann-Whitney U-test or Pearson's correlation coefficient *r*, analysis of variance or the Kruskal--Wallis test was in use to adequately evaluate group differences. For the categorical parameter analysis, Fisher's exact test or Pearson χ^2^ test was in use to evaluate group differences. Baseline items with significant correlation with the WS decline in our univariate analysis were subject to multivariate logistic regression analysis to choose candidate items. Unless otherwise mentioned, data were shown as the median value (range). The statistical significance threshold was set at *p* \< 0.05.

3. Results {#sec3-jcm-09-00166}
==========

3.1. Baseline Features {#sec3dot1-jcm-09-00166}
----------------------

Baseline features of the analyzed subjects (n = 356) are presented in [Table 1](#jcm-09-00166-t001){ref-type="table"}. The study cohort included 165 males and 191 females with the median age (range) of 66 (25--94) years. In terms of the disease etiology for CLD, hepatitis C virus was in the majority (181/356, 50.8%). The median (range) WS was 1.3 m/s (0.2--2.02 m/s). Number distribution for the WS value is demonstrated in [Figure 1](#jcm-09-00166-f001){ref-type="fig"}A. The number of patients with 1.2 m/s \< WS \< 1.4 m/s was the highest (110 cases, 30.9%). LC was identified at baseline in 137 cases (38.5%). There were 17 patients with WS \< 0.8 m/s (4.8%) and 51 patients with WS \< 1.0 m/s (14.3%). In males, the median (range) HGS was 33.6 kg (13.6--53.6 kg), while in females, the median (range) HGS was 20.5 kg (6.0--34.8 kg). Twenty-eight males (17.0%) and 57 females (29.8%) had the HGS decrease (HGS: \<26 kg or \<18 kg). In males, the median (range) SMI was 7.475 kg/m^2^ (5.21--11.01 kg/m^2^), while in females, the median (range) SMI was 5.875 kg/m^2^ (3.90--8.17 kg/m^2^). The median (range) WS in LC patients (1.23 m/s (0.33--1.76 m/s) was significantly slower than that in non-LC patients (1.36 m/s (0.2--2.02 m/s); *p* \< 0.0001; [Figure 1](#jcm-09-00166-f001){ref-type="fig"}B). The difference of WS between patients aged \<65 years (n = 162) and those aged ≥65 years (n = 194) also reached significance (*p* \< 0.0001; median (range): 1.365 m/s (0.33--1.85 m/s) vs. 1.22 m/s (0.20--2.02 m/s); [Figure 2](#jcm-09-00166-f002){ref-type="fig"}A) The difference of WS between male patients and female patients did not reach significance (*p* = 0.5577; median (range): 1.28 m/s (0.2--2.02 m/s) vs. 1.31 m/s (0.33--1.84 m/s); [Figure 2](#jcm-09-00166-f002){ref-type="fig"}B).

3.2. Relationship between WS and HGS for All Cases, LC Cases and Non-LC Cases {#sec3dot2-jcm-09-00166}
-----------------------------------------------------------------------------

For all cases, the WS value was significantly correlated with the HGS value both in males (*r*^2^ = 0.252, *p* \< 0.0001) and females (*r*^2^ = 0.256, *p* \< 0.0001; [Figure 3](#jcm-09-00166-f003){ref-type="fig"}A,B). For LC cases, the correlation between the WS value and the HGS value reached significance in both males (*r*^2^ = 0.134, *p* = 0.0019) and females (*r*^2^ = 0.156, *p* = 0.0009; [Figure 4](#jcm-09-00166-f004){ref-type="fig"}A,B). For non-LC cases, the correlation between the WS value and the HGS value reached significance in both males (*r*^2^ = 0.277, *p* \< 0.0001) and females (*r*^2^ = 0.269, *p* = 0.0009; [Figure 4](#jcm-09-00166-f004){ref-type="fig"}C,D). In male patients, the proportion of patients with both HGS \< 26 kg (cutoff value in the JSH guidelines) and WS \< 0.8 m/s was 3.0% (5/165), while that with both HGS \< 26 kg and WS \< 1.0 m/s was 6.7% (11/165). In female patients, the proportion of patients with both HGS \< 18 kg (cutoff value in the JSH guidelines) and WS \< 0.8 m/s was 2.6% (5/191), while that with both HGS \< 18 kg and WS \< 1.0 m/s was 8.9% (17/191) \[[@B10-jcm-09-00166]\].

3.3. Relationship between WS and SMI for All Cases, LC Cases and Non-LC Cases {#sec3dot3-jcm-09-00166}
-----------------------------------------------------------------------------

For all cases, the WS value was significantly correlated with the SMI value only in males (*r*^2^ = 0.039, *p* = 0.0111; [Figure 5](#jcm-09-00166-f005){ref-type="fig"}A,B). For LC cases, the correlation between the WS value and the HGS value did not reach significance in both males (*r*^2^ = 0.024, *p* = 0.1983) and females (*r*^2^ = 0.013, *p* = 0.3546; [Figure 6](#jcm-09-00166-f006){ref-type="fig"}A,B). For non-LC cases, the correlation between the WS value and the HGS value reached significance only in males (*r*^2^ = 0.097, *p* = 0.0022; [Figure 6](#jcm-09-00166-f006){ref-type="fig"}C,D).

3.4. Correlation Coefficients between WS and Baseline Parameters Other than HGS {#sec3dot4-jcm-09-00166}
-------------------------------------------------------------------------------

Correlation coefficients between WS and baseline parameters other than HGS are shown in [Table 2](#jcm-09-00166-t002){ref-type="table"}. Among these, serum albumin involved the strongest positive correlation with WS (*r* = 0.309146, *p* \< 0.0001), while the extracellular water (ECW) to total body water (TBW) ratio, as assessed by BIA, involved the strongest negative correlation with WS (*r* = −0.41169, *p* \< 0.0001).

3.5. Uni- and Multivariate Analyses of Factors Related to the WS Decline (\<0.8 m/s) {#sec3dot5-jcm-09-00166}
------------------------------------------------------------------------------------

The univariate analysis found six variables to have significant association with WS decline (\<0.8 m/s): age (*p* = 0.0278), presence of LC (*p* = 0.0088), serum albumin level (*p* = 0.0246), M2BPGi (*p* = 0.0141), branched-chain amino acid to tyrosine ratio (BTR; *p* = 0.0127) and ECW to TBW ratio (*p* \< 0.0001; [Table 3](#jcm-09-00166-t003){ref-type="table"}). Multivariate analysis for the six factors showed that only the ECW to TBW ratio (*p* = 0.0398) was a significant factor linked to WS decline (\<0.8 m/s; [Table 4](#jcm-09-00166-t004){ref-type="table"}). Hazard ratios (HRs) and 95% confidence intervals (CIs) are shown in [Table 4](#jcm-09-00166-t004){ref-type="table"}.

3.6. Uni- and Multivariate Analyses of Factors Related to the WS Decline (\<1.0 m/s) {#sec3dot6-jcm-09-00166}
------------------------------------------------------------------------------------

The national center for geriatrics and gerontology in Japan (National Institute for Longevity Sciences-Longitudinal Study of Aging (NILS-LSA)) and the International Working Group on Sarcopenia (IWGS) define the optimal cutoff point of WS for muscle function decline as \<1.0 m/s \[[@B17-jcm-09-00166],[@B28-jcm-09-00166]\]. Thus, uni- and multivariate analyses of factors related to WS decline (\<1.0 m/s) were also performed. The univariate analysis found seven factors to have significant association with WS decline (\<1.0 m/s): age (*p* \< 0.0001), presence of LC (*p* = 0.0124), serum albumin level (*p* = 0.0011), M2BPGi (*p* = 0.0016), BTR (*p* = 0.0289), ECW to TBW ratio (*p* \< 0.0001), and presence of SMI decline (*p* = 0.0037; [Table 5](#jcm-09-00166-t005){ref-type="table"}). In the multivariate analysis for the seven factors, no significant factor was found. Age (*P* = 0.0995) and ECW to TBW (*P* = 0.0556) tended to be significant. HRs and 95% CIs are shown in [Table 6](#jcm-09-00166-t006){ref-type="table"}.

3.7. WS Stratified by ECW to TBW Ratio {#sec3dot7-jcm-09-00166}
--------------------------------------

Based on the results of multivariate analyses, we further examined the impact of the ECW to TBW ratio on WS decline. Extracellular fluid excess was categorized as the following three types: normal condition (ECW to TBW ratio \< 0.390, n = 178), mild overhydrated condition (ECW to TBW ratio 0.390--0.399, n = 118) and moderate to severe overhydrated condition (ECW to TBW ratio ≥ 0.400, n = 58) \[[@B29-jcm-09-00166]\]. As shown in [Figure 7](#jcm-09-00166-f007){ref-type="fig"}, the WS value was well stratified according to the ECW to TBW ratio (*p*-values: normal vs. mild, *p* = 0.0001; mild vs. moderate to severe, *p* \< 0.0001; normal vs. moderate to severe, *p* \< 0.0001; overall *p-*value \< 0.0001).

4. Discussion {#sec4-jcm-09-00166}
=============

Physical activity has been considered a factor of interest in recent research. Previous data indicate that functional measures of muscle strength may have better predictability for outcomes than CT-based measures of skeletal muscle mass in LC patients \[[@B30-jcm-09-00166]\]. As mentioned earlier, the current JSH guidelines for sarcopenia in CLDs adopt not WS but only HGS for the assessment of muscle strength decline and few research papers report data for WS in Japanese CLD patients \[[@B10-jcm-09-00166],[@B18-jcm-09-00166],[@B19-jcm-09-00166]\]. Several reports have demonstrated that physical function precedes cognitive decline; however, the effects of HGS decline and WS decline on cognitive decline in adults may be different \[[@B20-jcm-09-00166],[@B31-jcm-09-00166],[@B32-jcm-09-00166],[@B33-jcm-09-00166]\]. We, therefore, believe that to elucidate factors related to WS decline may be clinically meaningful.

In our data, the median (range) WS was 1.3 m/s (0.2--2.02 m/s) and there were only 17 patients with WS \< 0.8 m/s (4.8%), which were in line with previous Japanese data \[[@B21-jcm-09-00166]\]. In other words, as we expected, a small proportion of our study subjects had WS decline. In order to demonstrate the usefulness as a screening tool of WS for muscle strength decline, the cutoff value of WS \< 1.0 m/s can be considered, as recommended by the NILS-LSA and IWGS, while the significant difference of the WS values between elderly and younger patients and that between LC and non-LC patients well reflected primary and secondary sarcopenia in CLDs \[[@B10-jcm-09-00166]\].

The WS value was significantly correlated with the HGS value both in males and females for all cases, LC patients and non-LC patients, in this study. However, there are some cases where there was a gap between the WS value and the HGS value, as shown in [Figure 3](#jcm-09-00166-f003){ref-type="fig"}A,B. The improvement in WS requires quick movement, whereas the improvement in the HGS does not require it and this may account for our current results. Both maintained cognitive function and muscle strength may be necessary for the improvement of WS, while even if cognitive function is reduced, the HGS value will not decrease as long as muscle strength is maintained \[[@B20-jcm-09-00166],[@B34-jcm-09-00166]\]. While the correlation coefficient between the WS value and SMI was not impressive compared with that between the WS value and the HGS value, muscle function and muscle mass may play different roles for the development of sarcopenia \[[@B19-jcm-09-00166],[@B30-jcm-09-00166]\].

The ECW to TBW ratio is an independent factor linked to the WS decline (\<0.8 m/s) and tends to be a significant factor linked to WS decline (\<1.0 m/s) in our multivariate analysis. In addition, the WS value was well stratified according to the ECW to TBW ratio (normal condition, mild edematous condition, and moderate to severe edematous condition). The ECW to TBW ratio suggests extracellular fluid status (water homeostasis), including the whole body \[[@B29-jcm-09-00166]\]. Excessive extracellular fluid may lead to the cognitive decline, and subsequent WS decline, which may be linked to our results \[[@B35-jcm-09-00166],[@B36-jcm-09-00166]\].

In our previous investigation, we found that M2BPGi, a novel liver fibrosis marker, significantly correlated with the HGS value in both males (*r* = −0.4611, *p* \< 0.0001) and in females (*r* = −0.33326, *p* \< 0.0001) \[[@B37-jcm-09-00166]\]. While in this study, the correlation coefficient between the WS value and M2BPGi was −0.2555 (*p* \< 0.0001), which was slightly different from that between HGS and M2BPGi. In view of these results, the HGS and the WS may not be the same for the evaluation of muscle strength. However, future investigations will be necessary to confirm these results.

Frailty as well as sarcopenia has received increasing scientific attention as a potential explanation of the health diversity of elderly persons these days \[[@B38-jcm-09-00166]\]. Frailty indicates a state in which physical activities have deteriorated due to age \[[@B39-jcm-09-00166]\]. Decreased HGS, decreased WS, and decreased SMI can be associated with frailty \[[@B40-jcm-09-00166]\]. In this study, the WS value was significantly correlated with the HGS value both in males and females and such tendencies were not observed in the correlation between WS and SMI. However, whether WS is more a sign of frailty or sarcopenia than HGS or SMI in CLD patients is unclear. Further research will be required.

Several limitations related to this study warrant mention. First, this was a single-center observational study with retrospective properties. Second, the study data was derived from population data on liver diseases in Japan, and additional studies on other races are needed to further validate and extend its application to other races. Third, the WS value can vary depending on various physical conditions. Fourth, large ascites patients who may be involved in WS decline were excluded because of the limitation of BIA, being the possibility of bias. Fifth, the effects of several diseases other than liver diseases that can affect WS (e.g., orthopedic diseases) were not fully examined. Finally, because of the cross-sectional nature of the data, the direction of association between baseline data and WS remains unknown. The results, therefore, must be interpreted with caution. Nevertheless, our study results indicate that the WS value in CLDs is well correlated with age or liver functional markers. Especially, an edematous state, as evaluated by BIA (i.e., the ECW to TBW ratio), was closely linked to WS decline. The HGS and WS should not be considered as the same assessment tool for muscle strength.
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![The WS value according to extracellular water (ECW) to total body water (TBW) as assessed by bioimpedance analysis. Normal condition indicates an ECW to TBW ratio \< 0.390 (n = 178), mild overhydrated condition indicates an ECW to TBW ratio 0.390--0.399 (n = 118) and moderate to severe overhydrated condition indicates an ECW to TBW ratio ≥0.400 (n = 58). Missing data for the ECW to TBW ratio, n = 2.](jcm-09-00166-g007){#jcm-09-00166-f007}

jcm-09-00166-t001_Table 1

###### 

Baseline characteristics (n = 356).

  Variables                         Number or
  --------------------------------- ----------------------
  Age (years)                       66 (25, 94)
  Gender, male/female               165/191
  HCV/HBV/HCV and HBV/NBNC          181/61/9/105
  Body mass index (kg/m^2^)         22.7 (14.6, 41.4)
  Walking speed (m/s)               1.3 (0.2, 2.02)
  Hand grip strength (kg, male)     33.6 (13.6, 53.6)
  Hand grip strength (kg, female)   20.5 (6.0, 34.8)
  Presence of LC, yes/no            137/219
  Total bilirubin (mg/dL)           0.8 (0.2, 5.1)
  Serum albumin (g/dL)              4.3 (2.0, 5.2)
  Prothrombin time (%)              91.2 (11.9, 122.9)
  Platelet count (×10^4^/mm^3^)     17.5 (1.4, 51.4)
  FIB-4 index                       2.16 (0.29, 30.98)
  M2BPGi (cutoff index)             1.255 (0.21, 11.93)
  SMI (kg/m^2^, male)               7.475 (5.21, 11.01)
  SMI (kg/m^2^, female)             5.875 (3.90, 8.17)
  ECW to TBW ratio                  0.389 (0.367, 0.425)
  AST (IU/L)                        25 (10, 222)
  ALT (IU/L)                        19 (5, 232)
  HbA1c (NGSP)                      5.7 (3.7, 12.6)
  eGFR (ml/min/1.73 m^2^)           81 (5, 173)
  Serum zinc (μg/dL)                73.9 (22.0, 124.6)
  BTR                               5.65 (1.69, 13.82)
  Serum ammonia (μg/dL)             38 (12, 206)

HCV: hepatitis C virus, HBV: hepatitis B virus, NBNC: non-B and non-C, HCC, LC: liver cirrhosis, M2BPGi: Mac-2 binding protein glycosylation isomer, SMI: skeletal muscle index, ECW: extracellular water, TBW: total body water, AST: aspartate aminotransferase, ALT: alanine aminotransferase, NGSP: National Glycohemoglobin Standardization Program, eGFR: estimated glomerular filtration rate, BTR: branched-chain amino acid to tyrosine ratio.

jcm-09-00166-t002_Table 2

###### 

Correlation between walking speed and baseline data other than handgrip strength.

                     *r*        *p-*Value
  ------------------ ---------- -----------
  Age                −0.3002    \<0.0001
  Body mass index    −0.02932   0.5825
  Total bilirubin    −0.07285   0.1702
  Serum albumin      0.309146   \<0.0001
  Prothrombin time   0.142872   0.0069
  Platelet count     0.091789   0.0837
  AST                −0.06229   0.2411
  ALT                0.02578    0.6278
  FIB-4 index        −0.17981   0.0007
  HbA1c (NGSP)       −0.05046   0.3459
  eGFR               0.090435   0.0884
  SMI, male          0.189214   0.0149
  SMI, female        0.091065   0.2127
  ECW to TBW ratio   −0.41169   \<0.0001
  BTR                0.252886   \<0.0001
  Serum zinc         0.195912   0.0011
  Serum ammonia      −0.16623   0.0039
  M2BPGi             −0.2555    \<0.0001

AST, aspartate aminotransferase; ALT, alanine aminotransferase; NGSP, National Glycohemoglobin Standardization Program; eGFR, estimated glomerular filtration rate; SMI, skeletal muscle index; ECW, extracellular water; TBW, total body water; BTR, branched-chain amino acid to tyrosine ratio; M2BPGi, Mac-2 binding protein glycosylation isomer.

jcm-09-00166-t003_Table 3

###### 

Univariate analyses of factors linked to walking speed (WS) decline (\<0.8 m/s).

  -----------------------------------------------------------------------------------------
  Variables                       WS ≥ 0.8 m/s\          WS \< 0.8 m/s\         *p-*Value
                                  (n = 339)              (n = 17)               
  ------------------------------- ---------------------- ---------------------- -----------
  Age (years)                     65 (29, 94)            71 (25, 83)            0.0278

  Gender, male/female             155/184                10/7                   0.3265

  HBV/HCV/HBV and HCV/NBNC        60/170/9/100           1/11/0/5               0.4852

  Body mass index (kg/m^2^)       22.7 (14.6, 41.4)      21.5 (17.7, 29.2)      0.3367

  Presence of LC, yes/no          125/214                12/5                   0.0088

  Total bilirubin (mg/dL)         0.8 (0.2, 5.1)         0.9 (0.4, 3.2)         0.7231

  Serum albumin (g/dL)            4.3 (2.0, 5.2)         4.0 (2.4, 4.6)         0.0246

  Prothrombin time (%)            91.4 (11.9, 122.9)     84.7 (46.5, 103.9)     0.1597

  Platelet count (×10^4^/mm^3^)   17.7 (1.4, 51.4)       16.0 (2.8, 32.2)       0.1401

  AST                             25 (12, 222)           27 (10, 191)           0.5570

  ALT                             19 (5, 206)            16 (5, 232)            0.2200

  M2BPGi                          1.24 (0.21, 11.93)     2.31 (1.08, 10.82)     0.0141

  eGFR (ml/min/1.73m^2^)          81 (5, 173)            76 (7, 99)             0.0931

  HbA1c (NGSP)                    5.7 (3.7, 12.6)        5.7 (4.6, 7.2)         0.3573

  Serum ammonia (μg/dL)           38 (12, 195)           48 (18, 206)           0.0534

  BTR                             5.71 (1.93, 13.82)     3.92 (1.69, 8.8)       0.0127

  Serum zinc (μg/dL)              73.9 (22.0, 124.6)     68.4 (38.0, 94.4)      0.0764

  ECW to TBW ratio                0.389 (0.367, 0.425)   0.398 (0.387, 0.421)   \<0.0001

  SMI decline, yes/no/unknown     114/223/2              7/10/0                 0.6024
  -----------------------------------------------------------------------------------------

Continuous data are expressed as median (range). HCV, hepatitis C virus; HBV, hepatitis B virus; NBNC, non-B and non-C; LC, liver cirrhosis; AST, aspartate aminotransferase; ALT, alanine aminotransferase; M2BPGi, Mac-2 binding protein glycosylation isomer; eGFR, estimated glomerular filtration rate; NGSP, National Glycohemoglobin Standardization Program; BTR, branched-chain amino acid to tyrosine ratio; ECW, extracellular water; TBW, total body water; SMI, skeletal muscle index.

jcm-09-00166-t004_Table 4

###### 

Multivariate analyses of factors linked to the walking speed decline (\<0.8 m/s).

                          Multivariate Analysis                           
  ----------------------- ----------------------- ----------------------- --------
  Age ^\#^                0.0267                  9.251 × 10^−5^--7.700   0.1594
  Presence of LC          0.779                   0.109--5.589            0.8040
  Serum albumin ^\#^      15.152                  0.0548--4184.100        0.3333
  M2BPGi ^\#^             0.764                   0.0117--49.763          0.8998
  BTR ^\#^                8.007                   0.0614--1044.325        0.3874
  ECW to TBW ratio ^\#^   0.00105                 1.387 × 10^−6^--0.795   0.0398

^\#^ When a continuous variable changes over the entire range. HR, hazard ratio; CI, confidence interval; LC, liver cirrhosis; M2BPGi, Mac-2 binding protein glycosylation isomer; BTR, branched-chain amino acid to tyrosine ratio; ECW, extracellular water; TBW, total body water.

jcm-09-00166-t005_Table 5

###### 

Univariate analyses of factors linked to walking speed (WS) decline (\<1.0 m/s).

  -----------------------------------------------------------------------------------------
  Variables                       WS ≥ 1.0 m/s\          WS \< 1.0 m/s\         *p-*Value
                                  (n = 305)              (n = 51)               
  ------------------------------- ---------------------- ---------------------- -----------
  Age (years)                     64 (29, 90)            73 (25, 94)            \<0.0001

  Gender, male/female             139/166                26/25                  0.5446

  HBV/HCV/HBV and HCV/NBNC        56/151/8/90            5/30/1/15              0.4421

  Body mass index (kg/m^2^)       22.9 (14.8, 41.4)      22.4 (14.6, 30.6)      0.1246

  Presence of LC, yes/no          109/196                28/23                  0.0124

  Total bilirubin (mg/dL)         0.8 (0.3, 5.1)         0.9 (0.2, 3.8)         0.9470

  Serum albumin (g/dL)            4.3 (2.0, 5.1)         4.1 (2.4, 5.2)         0.0011

  Prothrombin time (%)            91.4 (11.9, 122.9)     88.9 (33.4, 122.5)     0.1818

  Platelet count (×10^4^/mm^3^)   17.9 (1.4, 51.4)       16.9 (2.8, 34.5)       0.1531

  AST                             25 (12, 222)           24 (10, 191)           0.3413

  ALT                             20 (6, 206)            17 (5, 232)            0.6215

  M2BPGi                          1.2 (0.21, 11.93)      2.18 (0.47, 10.82)     0.0016

  eGFR (ml/min/1.73 m^2^)         81 (5, 173)            73 (7, 162)            0.0709

  HbA1c (NGSP)                    5.7 (3.7, 12.6)        5.7 (4.5, 9.8)         0.5730

  Serum ammonia (μg/dL)           38 (12, 195)           40 (14, 206)           0.7299

  BTR                             5.715 (1.93, 13.82)    5.07 (1.69, 10.0)      0.0289

  Serum zinc (μg/dL)              74.2 (22.0, 124.6)     69.5 (36.6, 118.2)     0.1474

  ECW to TBW ratio                0.389 (0.367, 0.425)   0.398 (0.368, 0.421)   \<0.0001

  SMI decline, yes/no/unknown     94/209/2               27/24/0                0.0037
  -----------------------------------------------------------------------------------------

Continuous data are expressed as median (range). HCV, hepatitis C virus; HBV, hepatitis B virus; NBNC, non-B and non-C; LC, liver cirrhosis; AST, aspartate aminotransferase; ALT, alanine aminotransferase; M2BPGi, Mac-2 binding protein glycosylation isomer; eGFR, estimated glomerular filtration rate; NGSP, National Glycohemoglobin Standardization Program; BTR, branched-chain amino acid to tyrosine ratio; ECW, extracellular water; TBW, total body water; SMI, skeletal muscle index.

jcm-09-00166-t006_Table 6

###### 

Multivariate analyses of factors linked to walking speed decline (\<1.0 m/s).

                          Multivariate Analysis                     
  ----------------------- ----------------------- ----------------- --------
  Age ^\#^                0.0638                  0.00205--1.989    0.0985
  Presence of LC          0.973                   0.320--2.957      0.9620
  SMI decline             0.606                   0.229--1.603      0.3132
  Serum albumin ^\#^      2.596                   0.0989--6.817     0.5665
  M2BPGi ^\#^             0.887                   0.0676--11.645    0.9275
  BTR ^\#^                1.121                   0.0760--16.540    0.9337
  ECW to TBW ratio ^\#^   0.0284                  0.000715--1.132   0.0556

^\#^ When a continuous variable changes over the entire range. HR, hazard ratio; CI, confidence interval; LC, liver cirrhosis; SMI, skeletal muscle index; M2BPGi, Mac-2 binding protein glycosylation isomer; BTR, branched-chain amino acid to tyrosine ratio; ECW, extracellular water; TBW, total body water.
